Report overview
Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
This report aims to provide a comprehensive presentation of the global market for Oxytocic Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxytocic Pharmaceuticals. This report contains market size and forecasts of Oxytocic Pharmaceuticals in global, including the following market information:
Global Oxytocic Pharmaceuticals Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Oxytocic Pharmaceuticals Market Sales, 2018-2023, 2024-2030, (K Pcs)
Global top five Oxytocic Pharmaceuticals companies in 2022 (%)
The global Oxytocic Pharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
We surveyed the Oxytocic Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxytocic Pharmaceuticals Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Oxytocic Pharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Natural Oxytocin
Synthetic Oxytocin Derivative
Global Oxytocic Pharmaceuticals Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Oxytocic Pharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
Global Oxytocic Pharmaceuticals Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Oxytocic Pharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oxytocic Pharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oxytocic Pharmaceuticals revenues share in global market, 2022 (%)
Key companies Oxytocic Pharmaceuticals sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Oxytocic Pharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oxytocic Pharmaceuticals, market overview.
Chapter 2: Global Oxytocic Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Oxytocic Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxytocic Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oxytocic Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
